Literature DB >> 19769733

Harnessing human dendritic cell subsets to design novel vaccines.

Jacques Banchereau1, Eynav Klechevsky, Nathalie Schmitt, Rimpei Morita, Karolina Palucka, Hideki Ueno.   

Abstract

Dendritic cells (DCs) orchestrate a repertoire of immune responses that endow resistance to infection and tolerance to self. DC plasticity and subsets are prominent determinants of the quality of elicited immune responses. Different DC subsets display different receptors and surface molecules and express different sets of cytokines/chemokines, all of which lead to distinct immunological outcomes. Recent findings on human DC subsets and their functional specialization have provided insights for the design of novel human vaccines.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19769733      PMCID： PMC2759267          DOI： 10.1111/j.1749-6632.2009.04999.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  44 in total

1.  Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria.

Authors:  Vincent Flacher; Marielle Bouschbacher; Estelle Verronèse; Catherine Massacrier; Vanja Sisirak; Odile Berthier-Vergnes; Blandine de Saint-Vis; Christophe Caux; Colette Dezutter-Dambuyant; Serge Lebecque; Jenny Valladeau
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Cell surface recycling of internalized antigen permits dendritic cell priming of B cells.

Authors:  Amy Bergtold; Dharmesh D Desai; Anamika Gavhane; Raphael Clynes
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

3.  Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells.

Authors:  Hai Qi; Jackson G Egen; Alex Y C Huang; Ronald N Germain
Journal:  Science       Date:  2006-06-16       Impact factor: 47.728

4.  Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition.

Authors:  Angelic M G van der Aar; Regien M R Sylva-Steenland; Jan D Bos; Martien L Kapsenberg; Esther C de Jong; Marcel B M Teunissen
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 5.  Translating innate immunity into immunological memory: implications for vaccine development.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 6.  Dendritic cell subsets in health and disease.

Authors:  Hideki Ueno; Eynav Klechevsky; Rimpei Morita; Caroline Aspord; Tinghua Cao; Toshimichi Matsui; Tiziana Di Pucchio; John Connolly; Joseph W Fay; Virginia Pascual; A Karolina Palucka; Jacques Banchereau
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

7.  Langerhans cells cross-present antigen derived from skin.

Authors:  Patrizia Stoitzner; Christoph H Tripp; Andreas Eberhart; Kylie M Price; Jae Y Jung; Laura Bursch; Franca Ronchese; Nikolaus Romani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-03       Impact factor: 11.205

8.  IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.

Authors:  Liang Zhou; Ivaylo I Ivanov; Rosanne Spolski; Roy Min; Kevin Shenderov; Takeshi Egawa; David E Levy; Warren J Leonard; Dan R Littman
Journal:  Nat Immunol       Date:  2007-06-20       Impact factor: 25.606

9.  Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production.

Authors:  Wei Cao; David B Rosen; Tomoki Ito; Laura Bover; Musheng Bao; Gokuran Watanabe; Zhengbin Yao; Li Zhang; Lewis L Lanier; Yong-Jun Liu
Journal:  J Exp Med       Date:  2006-05-30       Impact factor: 14.307

10.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

Authors:  Troy Querec; Soumaya Bennouna; Sefik Alkan; Yasmina Laouar; Keith Gorden; Richard Flavell; Shizuo Akira; Rafi Ahmed; Bali Pulendran
Journal:  J Exp Med       Date:  2006-02-06       Impact factor: 14.307
View more
  32 in total

1.  Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism.

Authors:  Collin J LaCasse; Nona Janikashvili; Claire B Larmonier; Darya Alizadeh; Neale Hanke; Jessica Kartchner; Elaine Situ; Sara Centuori; Michael Har-Noy; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

2.  Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.

Authors:  Hideki Fujita; Mayte Suárez-Fariñas; Hiroshi Mitsui; Juana Gonzalez; Mark J Bluth; Shali Zhang; Diane Felsen; James G Krueger; John A Carucci
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

Review 3.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 4.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

5.  An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.

Authors:  Michael A Morse; Amy C Hobeika; Takuya Osada; Peter Berglund; Bolyn Hubby; Sarah Negri; Donna Niedzwiecki; Gayathri R Devi; Bruce K Burnett; Timothy M Clay; Jonathan Smith; H Kim Lyerly
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

Review 6.  Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.

Authors:  Nicola Luigi Bragazzi; Andrea Orsi; Filippo Ansaldi; Roberto Gasparini; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

7.  Novel mechanisms underlying the immediate and transient global tolerization of splenic dendritic cells after vaccination with a self-antigen.

Authors:  Adam M Farkas; Olivera J Finn
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

Review 8.  Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.

Authors:  Knut Liseth; Elisabeth Ersvaer; Tor Hervig; Øystein Bruserud
Journal:  J Biomed Biotechnol       Date:  2010-06-02

9.  Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

Authors:  Ying Xie; Akgül Akpinarli; Charles Maris; Edward L Hipkiss; Malcolm Lane; Eun-Kyung M Kwon; Pawel Muranski; Nicholas P Restifo; Paul Andrew Antony
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

10.  Possible implication of local immune response in Darier's disease: an immunohistochemical characterization of lesional inflammatory infiltrate.

Authors:  Clelia Miracco; Francesco Pietronudo; Vasileios Mourmouras; Michele Pellegrino; Monica Onorati; Maria Grazia Mastrogiulio; Luca Cantarini; Pietro Luzi
Journal:  Mediators Inflamm       Date:  2010-06-30       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.